News Tagged ‘food and drug administration’

Tamoxifen with antidepressants may raise risk of breast cancer recurrence

The Food and Drug Administration (FDA) is expected to issue a warming to doctors about an increased risk of the recurrence of with patients taking both the drug tamoxifen and select antidepressants, according to a study released last week at the American Society of Clinical Oncology’s annual meeting.

Read the rest of this entry »

High court may bar claims for FDA-approved drugs

The U.S. Supreme Court will hear arguments today in the first of two cases this term that consumer advocates fear could shut courthouse doors to patients injured by FDA-approved drugs or medical devices.

Legal experts say the cases could also affect lawsuits already filed by tens of thousands of Americans challenging the safety of blockbuster drugs such as Celebrex and Prempro and a host of medical devices.

Read the rest of this entry »

Wyeth must pay $134.1 million in menopause drug lawsuit

Wyeth must pay $134.1 million, including $99 million in punitive damages, over its mishandling of menopause drugs that helped cause three Nevada women’s cancers, a jury ruled.

Read the rest of this entry »

Prempro lawsuit goes to the jury

After four weeks of testimony and a full day of closing arguments, jurors will begin deliberating this morning to decide whether pharmaceutical giant Wyeth is responsible for the suffered by three Northern Nevada women who took the company’s hormone replacement drugs.

Read the rest of this entry »